Novartis AG Cash on Hand 2010-2024 | NVS

Novartis AG cash on hand for the quarter ending June 30, 2024 was $8.435B, a 24.51% decline year-over-year.

  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
  • Novartis AG cash on hand for 2022 was $18.93B, a 33.18% decline from 2021.
  • Novartis AG cash on hand for 2021 was $28.329B, a 145% increase from 2020.

Novartis AG Cash on Hand 2010-2024 | NVS

  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
  • Novartis AG cash on hand for 2022 was $18.93B, a 33.18% decline from 2021.
  • Novartis AG cash on hand for 2021 was $28.329B, a 145% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$861.3B
Novo Nordisk (NVO)$592.4B
Johnson & Johnson (JNJ)$402.2B
AbbVie (ABBV)$341.7B
Merck (MRK)$299.6B
AstraZeneca (AZN)$243.5B
Pfizer (PFE)$169B
Sanofi (SNY)$144.1B
Innoviva (INVA)$1.2B